What is Oruka Therapeutics, Inc.'s asset turnover?

Oruka Therapeutics, Inc. (ORKA) reported asset turnover of 0× in Q2 2024.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Oruka Therapeutics, Inc. ORKA Asset turnover

Asset turnover at other companies

Bristol-Myers SquibbBMY

0.5×0.0×

Eli LillyLLY

0.7×+0.1×

Johnson & JohnsonJNJ

0.5×0.0×

AmgenAMGN

0.4×0.0×

AbbVieABBV

0.5×+0.1×

Kymera TherapeuticsKYMR

0×0.0×

Other financials

Income statement

See full

Revenue-—

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$5.03B+533%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Calculated from Oruka Therapeutics, Inc.’s reported figures.

total revenue/total assets=0×

Based on trailing twelve months.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed August 11, 2025, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s asset turnover?: Oruka Therapeutics, Inc. (ORKA) reported asset turnover of 0× in Q2 2024.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.